Intestinal inflammation as observed in inflammatory bowel disease (IBD) is a risk factor for the development of CRC 1 . Increasing evidence suggests that inflammation-associated pathways also contribute to CRC development in the absence of clinically overt intestinal inflammation 1 . Thus, signaling pathways with central roles in myeloid and lymphoid cells, such as those associated with signal transducer and activator of transcription 3 (STAT3) and nuclear factor (NF)-κB, are also active in the transformed intestinal epithelium and promote tumor development [2] [3] [4] [5] [6] .
Intestinal inflammation as observed in inflammatory bowel disease (IBD) is a risk factor for the development of CRC 1 . Increasing evidence suggests that inflammation-associated pathways also contribute to CRC development in the absence of clinically overt intestinal inflammation 1 . Thus, signaling pathways with central roles in myeloid and lymphoid cells, such as those associated with signal transducer and activator of transcription 3 (STAT3) and nuclear factor (NF)-κB, are also active in the transformed intestinal epithelium and promote tumor development [2] [3] [4] [5] [6] .
Calcineurin is a phosphatase with central functions in immunity, many of which are elicited by dephosphorylation and activation of NFAT transcription factors 7 (which we collectively refer to as NFAT). In accordance with an important role of calcineurin in immunity, calcineurin inhibitors are widely used to suppress undesired immune responses, particularly in solid organ transplantation. The pharmacological inhibition of calcineurin therefore leads to an increase in the incidence of solid cancers including CRC, presumably as a consequence of impaired calcineurin-dependent tumor immunosurveillance 8, 9 . In contrast to these observations in vivo, the blockade of calcineurin and NFAT in isolated CRC cell lines in vitro inhibits, rather than promotes, CRC cell growth [10] [11] [12] [13] , thus raising the question of whether epithelial calcineurin and NFAT exhibit cell-intrinsic oncogenic roles in CRC. Here we show that calcineurin and NFAT are constitutively expressed by IECs and undergo toll-like receptor (TLR)-induced activation in response to impaired stratification of the tumorassociated microbiota and increased TLR expression by tumor cells. Epithelial calcineurin promotes intestinal tumor development through the regulation of cancer stem cell function in mice, and its activation in human CRC is associated with increased death from CRC.
RESULTS

Epithelial calcineurin promotes intestinal tumor development
To investigate the role of epithelial calcineurin in intestinal tumor development, we generated mice with an IEC-specific deletion of the regulatory B1 subunit of calcineurin (Cnb1; encoded by Ppp3r1), which is required for calcineurin activation, using loxP-flanked ('floxed') alleles of Ppp3r1 and Cre-mediated deletion (villinCre;Ppp3r1 fl/fl mice; hereafter referred to as Cnb1 ∆IEC mice). Cnb1 ∆IEC mice were crossed with Apc Min/+ mice 14 , which have one mutated allele of the adenomatosis polyposis coli (Apc) gene and are a model for genetically induced intestinal tumors. The IEC-specific loss of Cnb1 ( Supplementary Fig. 1a,b) did not affect epithelial differentiation ( Supplementary Fig. 1c,d ), but it was associated with reduced intestinal tumor multiplicity and size, as compared to villin-Cre-negative wild-type (WT) littermates (Ppp3r1 fl/fl ;Apc Min/+ mice, hereafter referred to as Cnb1 WT ;Apc Min/+ mice; Fig. 1a,b and Supplementary  Fig. 1e ). Early-stage lesions, such as microadenomas, were also reduced in Cnb1 ∆IEC ;Apc Min/+ mice, consistent with calcineurin-dependent regulation of tumor initiation (Supplementary Fig. 1f) . Furthermore, deletion of Ppp3r1 in established tumors of 12-week-old villinCreER T2 ;Ppp3r1 fl/fl ;Apc Min/+ -a model with tamoxifen-inducible, IEC-specific deletion of Ppp3r1, which we refer to as Cnb1 ind∆IEC mice-was associated with decreased tumor size, in accordance with calcineurin-dependent tumor growth ( Fig. 1c and Supplementary  Fig. 1g ). Tumor multiplicity and size were also reduced in Cnb1 ∆IEC mice treated with colitis-inducing dextran sulfate sodium (DSS) in conjunction with the carcinogen azoxymethane (AOM) (Fig. 1d,e and Supplementary Fig. 1h ), despite an increase in body weight loss and an increase in the disease activity index (Supplementary Fig. 1i-k) . Thus, the tumor-promoting effects of epithelial calcineurin extend to the colon and to colitis-associated CRC. These results demonstrate that epithelial calcineurin supports intestinal tumor initiation and growth in mice.
We next addressed the mechanisms underlying calcineurindependent tumor development. Because tumorigenesis in Apc Min/+ mice recapitulates central steps of early intestinal tumor development in humans and occurs in the absence of clinically overt intestinal inflammation, similar to what is observed in the majority of human CRCs, we focused on the Apc Min/+ model for subsequent mechanistic studies. Epithelial proliferation was reduced and apoptosis was increased in Cnb1-deficient adenomas and microadenomas, whereas senescence was not observed (Fig. 1f,g, Supplementary Fig. 2a,b and data not shown (K.P.)). Cnb1-dependent regulation of proliferation and apoptosis was not observed in normal IECs of Cnb1 ∆IEC ;Apc WT mice and was thus specific for the tumor-associated epithelium ( Supplementary Fig. 2c,d ). These data suggest that calcineurin supports intestinal tumor development through promotion of epithelial proliferation and inhibition of apoptosis.
Tumor-promoting effects of calcineurin are mediated by NFAT To identify the molecular mediators of calcineurin-dependent tumor growth, we investigated the role of the NFAT family of transcription factors, of which NFATc1, NFATc2, NFATc3 and NFATc4 are dependent on calcineurin for dephosphorylation and nuclear translocation 7 . NFATc3 was consistently expressed in primary human CRC and CRC cell lines, whereas other calcineurin-dependent NFAT members showed weak and inconsistent expression CRC cells, with occasional detection of NFATc1 in tumor-infiltrating cells but not in epithelial cells (Fig. 2a,b) . In mice, normal small intestinal epithelium showed exclusive expression of NFATc3 ( Supplementary Fig. 3a and data not shown (K.P.)). Apc Min/+ tumors demonstrated increased Nfatc3 expression, as compared to normal mucosa, but weak expression of Nfatc1, Nfatc2 and Nfatc4 (Fig. 2c,d and Supplementary Fig. 3b ). Consistent with calcineurin-dependent regulation of apoptosis and proliferation in tumors but not in normal epithelium (Fig. 1f,g and Supplementary Fig. 2c,d ), NFATc3 was cytoplasmic in normal IECs but showed calcineurin-dependent nuclear translocation in Apc Min/+ tumors (Fig. 2e) . Thus, NFATc3 is constitutively expressed by IECs, whereas its calcineurin-dependent activation is specific to intestinal tumors. Figure 1 Intestinal epithelial calcineurin promotes intestinal tumor development. (a-e) Number of total (a,d) and large (b,c,e) tumors in the small intestine of 18-week-old Cnb1 ∆IEC ;Apc Min/+ (n = 30) and Cnb1 WT ;Apc Min/+ (n = 24) littermates (a,b), the small intestine of 18-week-old Cnb1 ind∆IEC ;Apc Min/+ (n = 9) and Cnb1 WT ;Apc Min/+ (n = 11) littermates after tamoxifen treatment (c), and the large intestine of Cnb1 ∆IEC (n = 16) and Cnb1 WT (n = 13) mice in the AOM-DSS model (d,e). (f,g) Quantification of cells staining positive for Ki-67 (f, left) or cleaved caspase-3 (cCasp-3) (g, left), using immunofluorescence, and representative images showing staining for Ki-67 (green) (f, middle and right), cCasp-3 (green) (g, middle and right) and DAPI (blue) in tumors from the small intestines of 18-week-old Cnb1 WT ;Apc Min/+ (middle; n = 21 for Ki-67; n = 14 for cCasp-3) and Cnb1 ∆IEC ;Apc Min/+ (right; n = 11 for Ki-67; n = 12 for cCasp-3) mice. Scale bars, 100 µm. The combined results of two (d,e) or three (c) independent experiments, or nine independent litters (a,b,f,g), are shown. In a-g, dots represent individual mice, and bar indicates median. P values were calculated using the Mann-Whitney U-test. To address whether NFATc3 promotes tumor development downstream of calcineurin, we investigated mice with an IEC-specific deletion of Nfatc3 (villin-Cre;Nfatc3 fl/fl ; hereafter referred to as Nfatc3 ∆IEC mice). Both in the Apc Min/+ mice and in the AOM-DSS model, tumor size (Fig. 2f,g ) and proliferation ( Fig. 2h and Supplementary Fig. 3c ) were reduced in Nfatc3 ∆IEC mice as compared to that in their WT littermates, whereas the severity of colitis in the AOM-DSS model was not affected (Supplementary Fig. 3d ). Consistent with these observations, transduction of tumors with an adenoviral construct encoding calcineurin-independent, constitutively active NFATc3 (Ad-NFATC3 CA ) increased tumor growth in Cnb1 ∆IEC ;Apc Min/+ mice ( Fig. 2i and Supplementary Fig. 3e,f) . Ad-NFATC3 CA transduction did not further promote tumor growth in Cnb1 WT ;Apc Min/+ mice (Fig. 2i) , consistent with the idea that constitutive tumorassociated activation of NFATc3 occurs in the presence of functional calcineurin (Fig. 2e) .
Because the reduction in tumor size was more pronounced in Cnb1 ∆IEC mice than in Nfatc3 ∆IEC mice (Figs. 1b,e and 2f,g ) and because a reduction in tumor multiplicity was not observed in Nfatc3 ∆IEC mice (Supplementary Fig. 3g,h) , we investigated the role of other NFAT factors in intestinal tumor development. Deletion of Nfatc1 in intestinal epithelial cells (using villin-Cre;Nfatc1 fl/fl ;Apc Min/+ mice) did not affect tumor multiplicity or size, whereas tumor development in mice with a combined IEC-specific deletion of Nfatc1 and Nfatc3 was indistinguishable from that in Nfatc3 ∆IEC mice ( Supplementary  Fig. 3i and data not shown (K.P.)). Because a compensatory increase in Nfatc2 expression was detected in tumors from Nfatc3 ∆IEC mice (Supplementary Fig. 3j) , we considered the possibility that abrogation of NFAT-dependent tumor development may require the combined inhibition of all calcineurin-dependent NFAT factors to avoid escape mechanisms. We therefore treated Apc Min/+ mice with adenoviruses expressing VIVIT (Ad-VIVIT; Supplementary Fig. 4a ), a peptide (MAGPHPVIVITGPHEE) that interferes with calcineurin-dependent activation of NFAT 15 . Ad-VIVIT treatment resulted in reduced tumor size, multiplicity and proliferation, and it increased tumor apoptosis ( Fig. 2j and Supplementary Fig. 4b,c) Apc Min/+ , n = 6; Ad-NFATC3 CA : Cnb1 WT ;Apc Min/+ , n = 10) or without (Ad-LacZ: Cnb1 WT ;Apc Min/+ , n = 9; Cnb1 ∆IEC ;Apc Min/+ , n = 10; Ad-NFATC3 CA : Cnb1 WT ;Apc Min/+ , n = 7; Cnb1 ∆IEC ;Apc Min/+ , n = 9) antibiotics (i; see Online Methods), or of Cnb1 WT ;Apc Min/+ mice after administration of Ad-LacZ (n = 11 per group) or Ad-VIVIT (n = 12 per group) (j). In g,i,j, combined data for three (g), four (j) and six (i) independent experiments are shown. In all graphs, dots represent individual mice, and bar indicates median. P values were calculated using the Mann-Whitney U-test. npg through the activation of NFAT. In contrast, calcineurin did not affect epithelial NF-κB and STAT3 signaling (Supplementary Results and Supplementary Fig. 5 ).
Microbiota-dependent activation of epithelial calcineurin
We next aimed to determine the factors responsible for the activation of calcineurin and NFAT in intestinal tumors. Mutations in APC, TP53 (which encodes the tumor suppressor protein p53) and the KRAS oncogene contribute to human CRC development, and Ras, as well as mutant p53, can activate NFAT [16] [17] [18] . Furthermore, noncanonical Wnt signaling and growth factors can promote the activation of NFAT [19] [20] [21] [22] . However, we did not find evidence for a role of canonical or noncanonical Wnt signaling, p53, Ras or growth factor signaling in the activation of tumor-associated calcineurin (Supplementary Results and Supplementary Figs. 6 and 7) .
Recent work has revealed a central role of the microbiota, and its TLR-dependent recognition, in intestinal tumor development in humans [23] [24] [25] [26] and rodents [27] [28] [29] [30] [31] [32] . In the Apc Min/+ model, TLR-induced Myd88 signaling in the nonhematopoietic compartment 30 , and specifically in the IECs 33 , regulates tumor growth through control of epithelial proliferation and apoptosis 30, 32 . Accordingly, antibiotic treatment 34 and germ-free (GF) rederivation 28, 31 inhibit intestinal tumor development in Apc Min/+ mice. TLR agonists have been shown to activate calcineurin and NFAT in dendritic cells 35 , so we investigated whether signaling by TLR2 and TLR4, the TLRs most strongly induced in Apc Min/+ tumors ( Supplementary Fig. 8a ) and expressed by primary human CRC cells 36 and SW707 CRC cells (data not shown (K.P.)), promotes the activation of tumor-associated calcineurin. Stimulation of TLR4, and to a lesser extent TLR2, led to a sustained increase in intracellular Ca 2+ (Fig. 3a) , an increase in the DNA binding activity of NFAT ( Fig. 3b) , nuclear translocation of ectopically expressed NFATc3 fused to green fluorescent protein (NFATc3-GFP) ( Fig. 3c) and NFAT-dependent transcription in human CRC cells (Fig. 3d) . The TLR-induced increase in the DNA-binding activity of NFAT was inhibited by small hairpin RNA (shRNA)-mediated knockdown of PPP3R1, chelation of extracellular Ca 2+ by EGTA, the use of Ca 2+ -free medium, and chemical inhibition of calcium releaseactivated channels (CRACs) by 3,5-bis(trifluoromethyl)pyrazole (BTP) 2 and of phospholipase C by U73122 (Fig. 3e,f and Supplementary  Fig. 8b ). These results suggest that TLR stimulation promotes store-operated calcium entry, nuclear NFAT translocation and NFAT-dependent transcription in CRC cells.
Because TLR agonists can activate calcineurin and NFAT in CRC cells, we next assessed the role of TLR signaling in calcineurindependent tumor development. Exposure to lipopolysaccharide (LPS) increased the proliferation of human CRC cells in a calcineurin-and NFATc3-dependent manner (Fig. 3g) . Similarly, LPS promoted the growth and proliferation of organoids from tumors of Cnb1 WT ;Apc Min/+ but not Cnb1 ∆IEC ;Apc Min/+ mice ( Fig. 3h and Supplementary Fig. 8c ) through TLR4 ( Supplementary Fig. 8d ). We therefore investigated whether the microbiota and its recognition by TLRs are required for calcineurin-dependent tumor growth in vivo. To this end, Apc Min/+ mice were either crossed with mice deficient in Myd88 or treated with antibiotics ( Supplementary Fig. 8e) Fig. 8f ) prevented nuclear translocation of NFATc3 in Apc Min/+ tumors ( Fig. 4a) and reduced NFAT-dependent transcription in tumors from Cnb1 WT ;Apc Min/+ but not Cnb1 ∆IEC ;Apc Min/+ mice (Fig. 4b) . Moreover, antibiotic treatment reduced tumor multiplicity and size in Cnb1 WT ;Apc Min/+ but not Cnb1 ∆IEC ;Apc Min/+ mice (Fig. 4c,d ), which could be restored by transduction with Ad-NFATC3 CA (Fig. 2i, right and Supplementary  Fig. 8g ).
Together, these data demonstrate that the microbiota and its Myd88-dependent recognition are sufficient for activation of calcineurin in CRC cells in vitro and are required for calcineurindependent tumor development in vivo. Fig. 9a ) 5 , perturbation of microbial stratification associated with intestinal tumors (Supplementary Fig. 9b and refs. Fig. 8a and ref. 36 ) provide a mechanistic explanation for the pronounced activation of the calcineurin-NFAT pathway in tumors, as compared to that in healthy intestinal epithelium. Furthermore, differences in community structure (Fig. 4e) but not richness (Wilcoxon test P = 0.27 for Chao1 species-richness measure) of the transcriptionally active mucosa-adherent microbiota were observed between intestinal tumors and matched normal mucosa of Apc Min/+ mice. Among the major species-level operational taxonomic units (OTUs) (average relative abundance >0.5%), six differed between the microbiota associated with normal tissues and that associated with tumors from Apc Min/+ mice (Fig. 4f) . Notably, the OTUs that were increased in abundance in the tumor-associated microbiota belong to genera known to signal via TLR4 and Myd88-such as Escherichia and/or Shigella 37 , as well as Citrobacter 38 . These alterations at the genus level also correspond to the increased abundance of Enterobacteriaceae and Proteobacteria at the family and phylum level, respectively (Fig. 4g) . These data raise the possibility that, in addition to impaired bacterial stratification, specific alterations in bacterial communities may contribute to the TLR-dependent activation of calcineurin in intestinal tumors. This is further supported by findings obtained after antibiotic treatment (Supplementary Results and Supplementary Fig. 9c-f) . Notably, the IEC-specific deletion of Ppp3r1 did not affect the community structure of the commensal microbiota (Fig. 4e, Supplementary Results and Supplementary Fig. 10 ). As such, calcineurin does not regulate tumor development through effects on the composition of the commensal microbiota but rather through control of the epithelial response to tumor-associated changes in microbial stratification and composition. In addition, Fusobacterium nucleatum (a bacterium that promotes intestinal tumor development 25, 29 ) and endogenous damage-associated molecular pattern molecules (such as the TLR4 ligand high-mobility group box 1 (HMGB1) and the HMGB1-binding receptor for advanced glycation end products (RAGE)) did not contribute to calcineurin-dependent regulation of intestinal tumor development (Supplementary Results and Supplementary Fig. 11 ).
Impaired barrier function in mice harboring intestinal tumors (Supplementary
5,23-25) and increased TLR expression by tumor cells (Supplementary
P = 0
Calcineurin regulates tumor stem cell function
We next studied the molecular mechanisms of calcineurin-and NFAT-dependent tumor development. Because we did not observe any indirect effects of epithelial calcineurin on tumor-infiltrating cells (Supplementary Results and Supplementary Fig. 12a-c Fig. 12d ). Because tumors from Cnb1 ∆IEC and Nfatc3 ∆IEC mice exhibited reduced proliferation (Figs. 1f and 2h ) and because tumor growth originates from proliferating intestinal stem cells 43 , which also exhibit strong nuclear NFATc3 expression as revealed in mice expressing EGFP under the control of the leucine-rich repeat-containing G protein-coupled receptor 5 (Lgr5) promoter (Lgr5-EGFP-IRES-CreER T2 mice 43, 44 ) (Fig. 5a) , we investigated the expression of stem cell-associated genes in tumors from Cnb1 ∆IEC ;Apc Min/+ mice. Expression of Lgr5, olfactomedin 4 (Olfm4), doublecortin-like kinase 1 (Dclk1), tumor necrosis factor receptor superfamily, member 19 (Tnfrsf19) and the CRC-associated variant exon (v) 6 splice variant of CD44 antigen (Cd44v6; refs. 45, 46) were reduced in tumors from Cnb1 ∆IEC ;Apc Min/+ mice (Fig. 5b,c) , antibiotic-treated Cnb1 WT ;Apc Min/+ but not Cnb1 ∆IEC ;Apc Min/+ mice ( Fig. 5b) and Ad-VIVIT-treated mice (as compared to Ad-LacZtreated Apc Min/+ mice) (Fig. 5d) , and were partially reduced in tumors from Nfatc3 ∆IEC ;Apc Min/+ mice ( Supplementary Fig. 12e and data not shown (K.P.)). In accordance with the tumor-specific activation of calcineurin, normal Lgr5 + intestinal stem cells in Apc WT mice showed predominantly cytoplasmic NFATc3 staining (Supplementary Fig. 12f) , which is consistent with unimpaired Lgr5, Olfm4 and Dclk1 expression (Supplementary Fig. 12g ) and with unaffected proliferation of normal IECs in Cnb1 ∆IEC mice (Supplementary Fig. 2c ). CD44 is a CRC stem cell marker, whose deletion in Apc Min/+ mice leads to increased tumor apoptosis and reduced tumor multiplicity 46 .
Similarly, CD44 splice forms containing variant exons, such as Cd44v6, identify human CRC stem cells 47 , are of negative prognostic value in human CRC 45 and promote tumor development in the Apc Min/+ model 48 . Consistent with the observation that apoptosis in Cd44-deficient Apc Min/+ tumors predominantly affects the stem cell compartment 46 , reduced numbers of eGFP + tumor stem cells were detected in Lgr5-EGFP-IRES-CreER T2 ;Cnb1 ∆IEC ;Apc Min/+ mice as compared to those in Cnb1 WT littermates (Fig. 5e) . This reduction in the number of eGFP + stem cells could be distinguished from a decrease in the mean eGFP expression per cell as a consequence of reduced NFAT-dependent activation of the Lgr5 promoter ( Fig. 5f ; for NFAT-dependent Lgr5 transcription see next paragraph). Furthermore, consistent with the observation of a reduction in the number of stem cells, tumors obtained from Cnb1 ∆IEC ;Apc Min/+ mice gave rise to decreased numbers of organoids, as compared to those from Cnb1 WT ;Apc Min/+ littermates (Fig. 5g) .
The presence of NFAT-binding consensus sites in the promoters of Cd44, Lgr5, Olfm4 and Dclk1 (Supplementary Fig. 13a-d) and the recent description of NFATc1 binding to Lgr5 and Dclk1 in hair follicle stem cells 49 further raised the question of whether alterations in direct NFAT-dependent transcription contribute to the decreased expression of stem cell-associated genes in Cnb1 ∆IEC ;Apc Min/+ tumors. Indeed, NFATc3 exhibited calcineurin-dependent binding to the promoters of Cd44, Lgr5, Olfm4 and Dclk1 in intestinal tumors in vivo, as determined by chromatin immunoprecipitation (ChIP)-qPCR analysis (Fig. 5h) . Moreover, even in eGFP + stem cells sorted from Cnb1 ∆IEC ;Apc Min/+ tumors, thus avoiding indirect effects owing to a loss of stem cells, expression of Cd44v6, Lgr5, Olfm4 and Dclk1 were reduced as compared to stem cells obtained from Cnb1 WT ;Apc Min/+ tumors (Fig. 5i) . Also, shRNA-mediated knockdown of PPP3R1, and to a lesser degree of NFATC3, was associated with decreased LGR5 expression in SW707 human CRC cells ( Supplementary  Fig. 13e ), whereas CD44, OLFM4 and DCLK1 were not expressed in this cell line. Together these data suggest that alterations in direct NFAT-dependent transcription, as well as a loss of tumor stem cells, contribute to decreased expression of stem cell-associated genes in Cnb1 ∆IEC ;Apc Min/+ tumors.
Cnb1-deficient Apc Min/+ tumors and SW707 CRC cells showed reduced nuclear β-catenin expression and decreased T cell factor (TCF)-and lymphoid enhancer factor (LEF)-dependent transcription (Fig. 5j) , respectively, suggesting positive regulation of Wnt signaling by epithelial calcineurin. Consistent with the observations that Lgr5 can promote canonical Wnt signaling through the binding of R-spondins 50 and that the expression of Lgr5 was reduced in Cnb1-deficient Apc Min/+ tumors (Fig. 5b) and SW707 CRC cells with stable knockdown of PPP3R1 (Supplementary Fig. 13e ), adenoviral-mediated expression of Lgr5 in Cnb1 ∆IEC ;Apc Min/+ tumors ( Supplementary  Fig. 13f ) partially restored nuclear β-catenin expression (Fig. 5j, left) and clonogenicity, as well as growth, in organoid cultures (Fig. 5j) . In contrast, Ad-LGR5 transduction had negligible effects on β-catenin expression (Fig. 5j, left) and on organoid growth and clonogenicity (Fig. 5j, right) in Cnb1 WT ;Apc Min/+ mice. These results suggest that calcineurin-dependent regulation of Lgr5 expression supports tumor stem cell function and contributes, among other pathways, to calcineurin-dependent promotion of tumor development.
NFAT activation is associated with reduced CRC survival Calcineurin expression and activity are increased in human CRC 51 and the growth of human CRC cells in vitro is dependent on calcineurin and NFATc3 (Fig. 3g) . This suggests, similar to observations in mice, npg that calcineurin and NFAT regulate human CRC development. To further address this question, we investigated whether NFATc3 activation and nuclear translocation in human CRC are associated with cancer-related death in individuals with CRC. We stained for NFATc3 in CRC samples from 704 individuals for whom survival data was available for at least 5 years after diagnosis. In accordance with the observation of nuclear NFATc3 translocation in intestinal adenomas of Apc Min/+ mice and thus at early stages of the adenoma-carcinoma sequence, nuclear NFATc3 expression was already observed at the T1 stage of CRC, with little or no correlation with the T (r 2 = 0.004, P = 0.01), N (r 2 = 0.001, P = 0.2) and M (r 2 = 0.001, P = 0.3) stages or with tumor grade (r 2 = 0.00001, P = 0.9). However, strong nuclear NFATc3 staining (staining score 2 or 3; n = 593 individuals) was associated with reduced survival (analysis limited to death from CRC), as compared to that in individuals with little or no nuclear NFATc3 staining (staining score 0 or 1; n = 111 individuals). These results demonstrate that the activation and nuclear translocation of NFATc3 is associated with increased death of individuals from CRC (Fig. 6a) . 
npg
Recent exome and genome sequencing of samples from individuals with CRC revealed mutations in protein phosphatase 3 catalytic subunit beta (PPP3CB), which encodes the catalytic calcineurin subunit A (CnA)-β, that were associated with increased death of individuals from CRC 52, 53 (http://www.cbioportal.org). Among these variants, PPP3CB R410* is a nonsense mutation-containing allele that is predicted to be associated with loss of the autoinhibitory domain of CnA-β (ref. 54) . Consistently, ectopic expression of PPP3CB R410* but not of PPP3CB WT was associated with constitutive NFAT-dependent transcription in human SW707 CRC cells, which was also observed after shRNA-mediated silencing of PPP3R1 (Fig. 6b) . As such, human CRC is associated with increased calcineurin expression 51 and constitutively active CnA-β variants (Fig. 6b) 52, 53 , whereas activation of the calcineurin-NFAT pathway is associated with increased death of individuals from CRC (Fig. 6a) .
DISCUSSION
Host immunity plays a critical role in the regulation of CRC. In addition to central functions of bone marrow-derived innate and adaptive immune cells, immune-associated signaling pathways in epithelial cells can promote intestinal tumor development [2] [3] [4] [5] [6] . Here we found that calcineurin and NFAT, two members of a pathway involved in immunity, are constitutively expressed by IECs and undergo selective activation in tumor tissue as a result of increased TLR expression by tumor cells, as well as altered stratification of the tumor-associated microbiota. After being activated by microbiota-derived TLR ligands, epithelial calcineurin supported the survival and proliferation of tumor stem cells and promoted tumor development in an NFAT-dependent manner (Fig. 6c) .
These results support a role for microbial elements in the regulation of CRC 55, 56 and provide novel insight into the molecular pathways linking tumor-associated changes in the microbiota to oncogenic epithelial signaling. Recent work documented alterations in the composition of the commensal microbiota associated with CRC development, which were characterized by an increase in the abundance of bacteria that are known to promote tumor growth 23,25,29,56,57 . 36 , dysbiosis 23, 25, 63 and impaired stratification of the luminal microbiota 5, 25 allows for TLR-dependent, store-operated calcium entry via calcium release activated channels (CRACs). This leads to calcium-dependent calcineurin activation and NFAT-dependent transcription of stem cell-associated genes, which promote tumor proliferation and prevent apoptosis. AMPs, antimicrobial peptides; ER, endoplasmic reticulum; PLC-γ, phospholipase C gamma; MAMPs, microbe-associated molecular patterns; STIM1, stromal interaction molecule 1; IP 3 , inositol 1,4,5-trisphosphate.
npg
Tumor-promoting alterations in microbial composition thereby act together with defects in epithelial barrier function 5 and microbial stratification 5, [23] [24] [25] to enhance tumor growth in a manner dependent on signaling pathways in myeloid and epithelial cells 5, 24, 30, 33 . Using Apc Min/+ mice as a model of genetically driven intestinal tumor formation, we found bacterial translocation into intestinal adenomas, as well as an increase in the relative abundance of bacteria known to signal via TLR4 and Myd88. This suggests that defects in microbial stratification, as well as specific alterations in the composition of the commensal microbiota, contribute to the activation of oncogenic epithelial calcineurin. Notably, alterations in the tumor-associated microbiota were observed regardless of the IEC-specific deletion of calcineurin. This demonstrates that epithelial calcineurin does not regulate intestinal tumor development through effects on the composition of the commensal microbiota but rather through control of the epithelial response to changes in microbial composition and stratification along the adenoma-carcinoma sequence. In conclusion, these studies describe a novel epithelial pathway that integrates signals derived from the commensal microbiota to promote intestinal tumor development and that may be amenable to therapeutic targeting.
METhODS
Methods and any associated references are available in the online version of the paper. SW707 cells were transduced with lentiviruses expressing an shRNA directed against human PPP3R1 (TRCN0000002758), NFATC3 (TRCN0000014532) or a nontargeting control (nonmammalian shRNA control) (all from Sigma-Aldrich) at a multiplicity of infection of 5 in the presence of polybrene (8 µg/µl). Stably transduced cells were cloned using cloning cylinders, and clones were selected based on target gene knockdown as determined by quantitative PCR and reduced expression of an NFAT-dependent luciferase construct.
The open reading frame of human CnA (PPP3CB), with or without PPP3CB variants identified in CRC 52, 53 (http://www.cbioportal.org), was synthesized (GeneCust, Luxembourg) and subcloned into pcDNA3.1.
Calcium-flux measurements. Calcium-flux measurements were performed using a FlexStation 3 microplate reader (Molecular Devices, Biberach, Germany) 24 h after cells were plated in a 96-well flat-bottom plate. Calcium-loading dye (FLIPR Calcium 5 Assay Kit, Molecular Devices) was added according to the manufacturer's instructions with 1 h of incubation at 37 °C. Cells were then stimulated with Pam3CSK4 (10 µg/ml), LPS (1 µg/ml) or PMA (50 ng/ml) and ionomycin (1 mM).
Western blotting, nuclear extracts and electrophoretic mobility shift assays (EMSAs). Western blotting, nuclear extracts, and EMSAs were performed as described previously 82 . For EMSAs, probes were used that contain an NFAT-AP-1 consensus site (5′-CAAAAGGCGGAAAGAAACAGTCATTTC-3′) or an NF-κB consensus site (5′-AGTTGAGGGGACTTTCCCAGGC-3′). For EMSA and western blotting, cells were stimulated for 4 h with 1 µg/ml LPS (Sigma-Aldrich), 10 µg/ml Pam3CSK4 (InvivoGen, Toulouse, France), 100 µg/ml pIpC (InvivoGen), 10 µg/ml flagellin (InvivoGen), 100 µg/ml E. coli DNA (InvivoGen) or 50 ng/ml PMA (Sigma-Aldrich) and 1 mM ionomycin (Sigma-Aldrich). Where indicated, cells were incubated for 2 h with 2 mM EGTA (Life Technologies), 5 µM BTP2 (Merck Millipore, Darmstadt, Germany) or 10 µM U73122 (SigmaAldrich). For ERK1-ERK2 activation, the indicated cell lines were serum-starved for 2 h and treated with EGF or vascular endothelial growth factor (VEGF) at 10 ng/ml (PeproTech, Hamburg, Germany) for the indicated periods. Where indicated, YAMC, IMCE and IMCE-Ras cells were incubated at 33 °C with Ad-LacZ, Ad-VIVIT or Ad-Cn CA (which expresses truncated and constitutively active CnA-β) at a multiplicity of infection of 50 before further treatment or analysis. For western blotting, the following antibodies were used: anti-human and mouse NFATc1 (7A6, 1:200, Santa Cruz, Heidelberg, Germany), anti-human and mouse NFATc2 (4G6G5, 1:200, Santa Cruz), anti-human and mouse NFATc3 (M75 or F1, 1:200, Santa Cruz), anti-human and mouse NFATc4 (H74, 1:200, Santa Cruz), anti-human and mouse ERK1-ERK2 (137F5, 1:1,000, Cell Signaling Technology, Leiden, the Netherlands), anti-human and mouse phospho-ERK1-ERK2 (D13.14.4E, 1:1,000, Cell Signaling Technology), anti-human and mouse β-actin (A2066, 1:2,000, Sigma-Aldrich), anti-human and mouse Cnb1 (C0581, 1:3,000, Sigma-Aldrich), anti-human and mouse STAT3 (79D7, 1:1,000, Cell Signaling Technology), anti-human and mouse phospho-STAT3 (Y705, 1:1,000 Cell Signaling Technology), and anti-human and mouse Sp1 (ABE135, 1:1,000, Merck Millipore).
Luciferase assays. For luciferase assays in cultured cell lines, plasmids expressing firefly luciferase under control of a minimal NFAT-dependent promoter 83 (11783, Addgene, Cambridge, MA, USA), a TCF-LEF-dependent promoter 84 (TOPFlash, 12456, Addgene) or a NF-κB-dependent promoter (Promega, Mannheim, Germany) were transfected, along with a plasmid expressing Renilla luciferase (phRluc, Promega) for normalization of transfection efficacy, into cells. Where indicated, WT or mutated PPP3CB or an empty pcDNA3.1 was transfected along with the plasmids described above. 24 h after transfection with Lipofectamine 2000 (Life Technologies), according to the manufacturer's instructions, cells were stimulated using 1 µg/ml LPS (Sigma-Aldrich), 10 µg/ml Pam3CSK4 (InvivoGen), 100 µg/ml pIpC (InvivoGen), 10 µg/ml flagellin (InvivoGen), 100 µg/ml E. coli DNA (InvivoGen), 10 µg/ml cyclosporine A (Sigma-Aldrich), 400 ng/ml recombinant Wnt3a (R&D Systems, Minneapolis, MN, USA) or 50 ng/ml PMA (Sigma-Aldrich) and 1 µM ionomycin (SigmaAldrich). 16 h after stimulation, luciferase expression was analyzed with the Dual-Glo-Luciferase Assay System (Promega) according to the manufacturer's instructions using a FlexStation 3 (Molecular Devices). was collected after 4 h. Relative fluorescence units were measured in serum using a FlexStation 3 microplate reader (Molecular Devices). For staining, small intestines were embedded in Tissue-Tek O.C.T. compound (Sakura, Alphen aan den Rijn, the Netherlands), and sections were prepared using a Leica CM1850 (Leica Biosystems, Wetzlar, Germany). Sections were directly incubated with DAPI (1 µg/ml, Sigma-Aldrich) for 10 min at room temperature, washed, and embedded using FluorSave (Merck Millipore).
For senescence-associated staining, the Senescence β-galactosidase Staining Kit (Cell Signaling) was used according to the manufacturer's instructions. Sections of unfixed small intestines, embedded in Tissue-Tek O.C.T. compound, were used.
Live-cell imaging. For live-cell imaging, SW707 human CRC cells were transfected, using Lipofectamine 2000 according to the manufacturer's instructions (Life Technologies), with a construct expressing an NFATc3-GFP fusion protein 15 (21664, Addgene). 24 h after transfection, cells were stimulated with 1 µM LPS, and images were acquired using an FV1000 confocal laser-scanning microscope (Olympus, Hamburg, Germany) equipped with a U Plan S Apo 60× oil-immersion objective (numerical aperture (N.A.) 1.40) and Olympus Fluoview Software (3.0a).
Fluorescence in situ hybridization. For fluorescence in situ hybridization, tissues were incubated in Carnoy's fixative (46% ethanol, 46% glacial acetic acid, 8% chloroform) overnight and embedded in paraffin. Slides were incubated at 50 °C for 1 h with hybridization buffer (18% 5 M NaCl, 2% 1 M Tris-HCl pH 7.4, 0.5% SDS) and 25 ng of Cy3-labeled universal bacterial probe (Bact338, see Supplementary Table 1 for nucleotide sequence; Eurofins, Ebersberg Germany), washed for 5 min in washing buffer (900 mM NaCl, 2% 1 M Tris-HCl pH 7.4, 0.06% SDS), and incubated with DAPI (1 µg/ml, SigmaAldrich) for 5 min.
Flow cytometry and flow sorting. Flow cytometry was performed as described previously 85 . Briefly, tumors were excised, washed in PBS and incubated in Hank's balanced salt solution (HBSS, Biochrom) with 1 mg/ml collagenase D (Biochrom), 20 ng/ml DNase (Roche, Mannheim, Germany) and 50 µg/ml dispase II (Roche) for 30 min at 37 °C. Cells were passed through a 70-µm cell strainer (BD Biosciences), washed in PBS and incubated in FcR blocking reagent (Miltenyi Biotec, Bergisch Gladbach, Germany) in 0.5% BSA (SERVA Electrophoresis, Heidelberg, Germany) and 2 mM EDTA (Life Technologies) in PBS for 10 min at 4 °C. Fixable viability dye eFluor 450 (eBiosciences, Frankfurt, Germany) was added to all stainings for exclusion of dead cells, and cells were stained with monoclonal antibodies for 20 min at 4 °C. All antibodies were purchased from BioLegend (Fell, Germany), except for anti-CD8 (BD Biosciences). For the detection of iNKT cells, staining with PBS57-loaded CD1d tetramers (60 min, 4 °C, NIH Tetramer Core Facility, Atlanta, USA) was performed. Data were collected using a BD Biosciences FACSVerse and were analyzed using FlowJo (Tree Star Inc., Ashland, OR).
For sorting of eGFP + stem cells, cells were extracted as mentioned above. After passage through a 70-µm cell strainer, cells were incubated in 3 ml TrypLE (Life Technologies) including 2,000 U/ml DNase (Sigma-Aldrich) for 30 min at 37 °C, passed through a 40-µm cell strainer and then sorted using a BD FACSAria (BD Biosciences).
RNA extraction and quantitative PCR. RNA of tissue was extracted using the RNeasy Mini Kit (Qiagen, Hilden, Germany). 2 µg RNA were transcribed into cDNA using the High-Capacity cDNA Reverse-Transcription Kit (Life Technologies) and quantitative PCR was performed as described previously 78 . PCR primers are listed in Supplementary Table 1. RNA from the sorted cells was extracted using the Arturus PicoPure RNA Isolation Kit (Life Technologies) according to the manufacturer's instructions.
Chromatin immunoprecipitation (ChIP).
Tissue was cross-linked in 1.5% formaldehyde, and chromatin was purified using the SimpleChIP Plus Enzymatic Chromatin IP Kit (Cell Signaling Technology) according to the manufacturer's instructions. 10 µg of digested chromatin was incubated overnight at 4 °C with 5 µg anti-human and mouse NFATc3 antibody (M75, Santa Cruz) or isotype and were subsequently immunoprecipitated with Protein G magnetic beads. DNA was purified and analyzed by qPCR. Input chromatin without immunoprecipitation was used for normalization in qPCR. PCR primers are listed in Supplementary Table 1. 16S rRNA sequencing and analysis. Transcriptionally active 86 members of the mucosa-attached microbiota were analyzed by performing 16S rRNA amplicon sequencing using bacterial cDNA as template for PCR. RNA was extracted using the AllPrep DNA/RNA Mini Kit (Qiagen). Amplification of the V1-V2 region of the 16S rRNA gene was performed using the primer pair 27F and 338R with flanking multiplex identifier (MID)-adaptors 87 . Amplicons were sequenced on the Illumina MiSeq platform using the MiSeq V3 sequencing kit to produce 300-bp pair-end reads. Fastq sequences were merged using FLASH software 88 , and merged reads were then filtered based on quality (>90% of nucleotides must have quality score 30 or higher for every read). Chimeras were removed using Uchime v6.0.307 (ref. 89 ), and each sample was then subsequently normalized to 20,000 random reads per sample. Sequences were classified with RDP classifier 90 , and species-level OTUs were clustered de novo using Usearch v6.0.307 (ref. 91 ). All taxonomy tables were created using Perl scripts for the follow-up analysis. Statistical analysis of alpha-diversity and beta-diversity was carried out using the Vegan 92 package in R.
Statistical analysis. For data sets of unknown or skewed distribution, nonparametric statistical analysis was performed using the Mann-Whitney U test or, in case of multiple testing, the Kruskal-Wallis test followed by the Dunn's test for multiple comparisons, and individual samples, as well as the median, were plotted. In the case of Gaussian distribution, parametric statistical analysis was performed using the two-tailed Student's t-test or, in case of multiple testing, one-way ANOVA, and the mean ± s.e.m. were plotted. For the disease activity index (DAI) analysis, the Wilcoxon matched-pairs signed-rank test was applied. For survival analysis, the log-rank test was applied. For evaluation of colocalization of DAPI and NFATc3, the Pearson correlation coefficient was used. Measures of location and variability, as well as the statistical test applied, are indicated for each data set.
